San Ysidro Health Running DRES-POCAI RCT — 848 Patients, EyeArt Point-of-Care AI for Diabetic Retinopathy at CA FQHC
San Ysidro Health (San Diego CA FQHC) is running the most rigorous CA FQHC-based AI diabetic retinopathy trial currently underway. DRES-POCAI (Diabetic Retinopathy Screening with Point-of-Care AI) RCT: 848 patients across 2 FQHC sites, EyeArt-based point-of-care AI integrated with EHR.
Primary outcome: DR screening completion at 90 days. Funded by Gordon and Betty Moore Foundation + Kaiser Permanente AIM-HI. ClinicalTrials.gov NCT06721351. Trial protocol published in JAMA Network Open.
This positions San Ysidro Health as a national leader in FQHC AI vision deployment. Outcomes will inform NACHC/AOA/CHCF policy recommendations on autonomous AI DR screening reimbursement and FQHC capital deployment priorities.
Primary source
JAMA Network OpenAffected FQHCs
FQHC Talent. (2026, January 15). San Ysidro Health Running DRES-POCAI RCT — 848 Patients, EyeArt Point-of-Care AI for Diabetic Retinopathy at CA FQHC. Primary source: JAMA Network Open. Retrieved June 15, 2026, from https://www.fqhctalent.com/intel/san-ysidro-health-dres-pocai-rct-2026
More in Strategy & Tactics
Jun 1
Redding's Sunrise Mountain Wellness Center Closes June 30 — a Third Prop 1 / BHSA Peer-Support Closure in the North State
Jun 1
Lake County Closes 3 Prop 1 Peer Support Centers June 1 — Including the County's Only Tribal-Specific Mental-Health Hub
May 14
eClinicalWorks Launches healowIQ + AI Workbench + healow Genie at FQHC-Dedicated Health Center Summit
May 7
Artera Launches AI Services Model + Agentic AI Squads — First Vendor to Package Agentic AI for 300 FQHC Customer Base